UCLA scientists have discovered a way to measure the amount of
amyloid beta that is being absorbed by immune cells in the blood.
Amyloid beta forms the plaques considered the hallmark of
Alzheimer's disease, and if the immune system isn't adequately
clearing amyloid beta, it may indicate Alzheimer's risk, according to